FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

2469011000001101: Xyloproct ointment (AstraZeneca) 30 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25382901000001117 Xyloproct ointment (AstraZeneca) 30 gram (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
103460301000001112 Xyloproct 5%/0.275% ointment (Aspen Pharma Trading Ltd) 30 gram en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xyloproct ointment (AstraZeneca) 30 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Is a Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 30 gram true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Is pack of Xyloproct ointment (AstraZeneca) false Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Has active ingredient Hydrocortisone acetate false Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Has active ingredient Lidocaine false Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Has excipient Cetyl alcohol false Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Has excipient Stearyl alcohol false Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Has AMP Xyloproct ointment (AstraZeneca) true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Has specific active ingredient Hydrocortisone acetate true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Has specific active ingredient Lidocaine true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Xyloproct ointment (AstraZeneca) 30 gram Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start